Attached files
| file | filename |
|---|---|
| EX-32.2 - Brooklyn ImmunoTherapeutics, Inc. | ex32-2.htm |
| EX-32.1 - Brooklyn ImmunoTherapeutics, Inc. | ex32-1.htm |
| EX-31.2 - Brooklyn ImmunoTherapeutics, Inc. | ex31-2.htm |
| EX-31.1 - Brooklyn ImmunoTherapeutics, Inc. | ex31-1.htm |
| EX-21.1 - Brooklyn ImmunoTherapeutics, Inc. | ex21-1.htm |
| 10-K - Brooklyn ImmunoTherapeutics, Inc. | form10-k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement Nos. 333-167352, 333-122024, 333-60814, 333-17247, 333-12777, and 033-95776 on Form S-8, and in the Registration Statement Nos. 333-178641, 333-111538, 333-105429, 333-51650, 333-80143, 333-69383, 333-40625, 333-14129, 333-192496, 333-193012 and 333-215271 on Form S-3 of NTN Buzztime, Inc. and subsidiaries of our report dated March 9, 2017, relating to the consolidated financial statements appearing in this Annual Report on Form 10-K of NTN Buzztime, Inc. and subsidiaries for the year ended December 31, 2016.
| /s/ SQUAR MILNER LLP |
Newport Beach, California
March 9, 2017